US Corporate Distress Financial Stress SEC Filings — June 18, 2026

USA Corporate Distress & Bankruptcy

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

This digest covers 50 filings from June 18, 2026, revealing a pronounced bifurcation in corporate health. A clear theme is the aggressive use of capital markets by distressed companies to stave off insolvency, with 6 at-the-market (ATM) offerings and 3 private placements totaling over $500 million in potential dilution.

Conversely, several firms are successfully refinancing debt on favorable terms, extending maturities by 2-4 years and improving balance sheet flexibility. The most critical distress signals are concentrated in micro-cap and pre-revenue biotech/tech companies, with 2 Nasdaq delisting notices (Dyadic International, Algorhythm Holdings) and one terminated SPAC merger (Papaya Growth Opportunity Corp. I). A notable sector theme is the high cost of distress financing, with companies like Nuvve Holding and CoreWeave agreeing to interest rates of 39% and 9.625% respectively, highlighting a two-tiered credit market. Insider trading data was sparse across these filings, but the prevalence of dilutive financing structures (convertible notes, preferred stock exchanges) signals significant shareholder value destruction for existing holders in distressed names.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from June 17, 2026.

Investment Signals (10)

  • Extended senior secured term loan maturity by 4 years (to 2033) and receivables facility by 2 years, citing strong lender demand. This signals improved balance sheet flexibility and management confidence in the 'One BrightView' strategy.

  • Refinanced term loans, adding $300M in incremental debt while reducing interest rate margins by 0.25% if leverage falls below 2.95x. The ability to upsize debt at better terms signals strong credit quality and growth appetite.

  • Sold a Rare Pediatric Disease Priority Review Voucher for $195M in gross proceeds. This non-dilutive capital infusion provides a multi-year runway to advance a deep clinical pipeline, including programs for Alzheimer's and Parkinson's.

  • All-stock merger creating a pro-forma NAV of $613M and portfolio of $771M. The combined entity is expected to have enhanced scale and liquidity, with a potential $25M stock repurchase program.

  • Take-private transaction by Trian and General Catalyst to close June 30, 2026, at $52/share. Overwhelming shareholder approval and all regulatory clearances received signal a clean exit for public shareholders.

  • Entered a $1.5M term loan with a 39% effective interest rate ($585k interest on $1.5M principal) and weekly payments of $43k. This is a classic sign of severe financial distress and desperation for cash.

  • Received Nasdaq deficiency notice for bid price <$1.00. With a 180-day cure period but no clear path to profitability, the risk of delisting and further equity dilution via a reverse split is high.

  • Received delisting notification for failing to meet both the bid price rule and continued listing standards (shareholders' equity <$5M). The company's plan to request a hearing provides only a temporary stay.

  • Business Combination Agreement terminated by target, citing alleged breaches by the SPAC. The deal's collapse introduces significant uncertainty, potential legal costs, and likely liquidation risk for the SPAC.

  • Filed for a $300M ATM offering, with proceeds to develop data centers and buy Bitcoin. The massive potential dilution, combined with a planned divestiture of a core subsidiary, signals a high-risk, speculative capital structure.

Risk Flags (10)

  • The $1.5M loan with $585k interest (39% APR) and weekly payments of $43k creates an unsustainable cash burn. A 25% default fee on non-payment indicates a high probability of default or further distressed financing.

  • Failed to meet both the Bid Price Rule and Continued Listing Standards (equity <$5M). The hearing request is a temporary stay; without a rapid capital infusion or reverse split, delisting is imminent.

  • Target terminated the merger citing breaches. The SPAC disputes this, but the deal's collapse leaves it with no operating business and a ticking clock to find a new target or liquidate.

  • Bid price below $1.00 for 30 consecutive days. The company is considering a reverse stock split, which is a temporary fix that often precedes further price declines and does not address underlying business weakness.

  • The $300M ATM offering represents a massive potential dilution. Management's broad discretion over proceeds (Bitcoin, data centers, working capital) adds uncertainty and risk for existing shareholders.

  • The $8.1M in operational funding from Hazel Partners is at the lender's sole discretion, with no guarantee of further increases. This creates a high dependency on a single source of capital, a classic distress signal.

  • Issued 30 shares of Series D Convertible Preferred for only $27k in cash. The cumulative authorized shares (167) and conversion features will cause significant dilution to common shareholders.

  • Entered a $30M settlement to resolve PVC pipe antitrust litigation. While the company expects no material adverse effect, the settlement is a significant cash outflow and an admission of potential liability.

  • Peak Holdings terminated the PSA for an 80% interest in Paso Robles parcels. The loss of a $500k deposit and the termination itself signals a setback in the company's asset monetization strategy.

  • Closed a $2.21M private placement at $0.34/share, a price that suggests significant distress. The shares are unregistered, limiting liquidity and signaling a weak negotiating position for the company.

Opportunities (10)

  • The $195M PRV sale provides a multi-year cash runway without dilution. This de-risks the clinical pipeline for high-value CNS programs (Alzheimer's, Parkinson's, Sanfilippo) and makes the company an attractive M&A target.

  • The 4-year maturity extension on its term loan removes a near-term refinancing risk. With improved balance sheet flexibility, the company can focus on its 2030 strategic objectives and potential margin expansion.

  • The $300M incremental term loan provides firepower for organic growth or M&A in the fragmented infrastructure space. The lower interest rate margin (if leverage targets are met) is a positive incentive for deleveraging.

  • The all-stock merger with REFI creates a larger, more liquid BDC with a $613M NAV. The potential $25M stock repurchase program could provide downside support. The Q4 2026 closing timeline offers a defined catalyst.

  • Completed a $700M note offering at 4.75%, a relatively low cost for a regulated utility. The proceeds will fund capital expenditures, supporting rate base growth and future earnings.

  • The $1.25B and €2B note offerings at 9.625% and 8.5% respectively offer a high yield. While risky, the company's focus on AI infrastructure and the size of the offering suggest strong institutional demand.

  • The €650M note offering at 4.25% is being used to repay $1.675B of 3.95% notes due 2026. This refinancing extends maturities and manages a significant near-term debt maturity, improving the credit profile.

  • The swap of 4.2 billion Unicoins for $757M in real estate provides a tangible asset backing for the token. If the appraisals are validated, this could establish a floor value for the token and attract institutional interest.

  • The acquisition of NOMAD (utility-grade BESS) represents a complete strategic pivot from biotech to energy storage. If successful, the re-rating from a clinical-stage biotech to a high-growth energy company could be substantial.

  • The move from Delaware to Texas, with a classified board and supermajority voting requirements, could be a precursor to a strategic transaction or a defense against activism. The governance changes are worth monitoring.

Sector Themes (6)

  • Two-Tiered Credit Market

    A clear divide exists between investment-grade companies (Atmos Energy at 4.75%, BrightView extending maturities) and distressed names (Nuvve at 39% APR, CoreWeave at 9.625%). This suggests a 'flight to quality' within credit markets, where strong companies access cheap capital while weak ones pay a severe premium.

  • ATM and Dilutive Financing Wave

    6 companies (SS Innovations, Hyperscale Data, Epsilon Energy, Sensei Biotherapeutics, Commercial Vehicle Group, Silvercrest) filed ATM offerings totaling over $540M in potential equity sales. This is a classic sign of cash burn and an inability to access traditional debt markets, particularly in the micro-cap and pre-revenue biotech space.

  • SPAC Distress Continues

    The termination of the Papaya Growth Opportunity Corp. I merger adds to a growing list of SPAC failures. With two new SPAC IPOs (Cantor Equity Partners VII, Yorkville International) raising $450M, the market is still creating new vehicles, but the failure rate for finding and closing deals remains high.

  • Cannabis Sector Consolidation

    The Vireo Growth acquisition of C21 Investments is a consolidation play in the cannabis sector, aiming to create scale in Nevada (15 dispensaries). The all-stock structure and $3M termination fee indicate a buyer's market with significant deal risk.

  • Asset-Backed Securities (ABS) Market Active

    Two large ABS deals were filed (Exeter Auto at $1.29B, Ford Credit Auto Owner Trust), indicating robust demand for consumer debt-backed securities. The sub-prime auto loan deal (Exeter) with coupons up to 7.42% suggests a healthy risk appetite for yield in this segment.

  • Real Estate as a Distressed Asset Class

    Unicoin's swap of tokens for real estate and Limoneira's terminated property sale highlight real estate as a source of both opportunity and distress. The reliance on outdated appraisals (2021-2024) in the Unicoin deal underscores valuation uncertainty in the sector.

Watch List (8)

  • The company will request a hearing to appeal delisting. The outcome and any capital raise or reverse split announced before the hearing will be critical. Watch for any 8-K filings regarding the hearing date or a compliance plan.

  • The company has 180 days to regain the $1.00 bid price. Watch for announcements of a reverse stock split or other strategic alternatives. The stock's performance in the coming weeks will be a key indicator.

  • With the merger terminated, the SPAC has a limited time to find a new target or liquidate. Watch for any announcement of a new business combination or a liquidation proposal to shareholders.

  • The weekly payments of $43k starting June 19, 2026, will be a severe cash drain. Watch for any missed payments, default notices, or further distressed financing announcements.

  • The $300M ATM program is active. Monitor daily trading volumes and share price for signs of aggressive selling. The company's use of proceeds (Bitcoin, data centers) is a high-risk strategy worth tracking.

  • The acquisition is expected to close on or about July 1, 2026. The $6.5M pre-closing loan and the subsequent name change to NOMAD Power Solutions will be key catalysts. Watch for the closing 8-K.

  • Chicago Atlantic BDC & REFI / Merger Vote
    👁

    The merger is subject to stockholder approvals from both companies. Watch for the record date and meeting date announcements. The actual ownership split (currently estimated at 50.5% for REFI holders) will depend on NAV calculations.

  • The $30M antitrust settlement requires preliminary and final court approval. Any objections or delays in the court process could impact the timeline and final cost.

Filing Analyses (50)
Motorsport Games Inc. 8-K neutral materiality 3/10

18-06-2026

Motorsport Games Inc. filed an 8-K on June 18, 2026, reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation (Item 2.03). The filing does not disclose the counterparty, transaction value, or specific terms, limiting the ability to assess materiality. No financial metrics, guidance, or scheduled events are provided.

  • · Filing size: 2 MB (suggests exhibits may be attached, but not analyzed here).
  • · No financial statements or pro forma data provided in the summary.
  • · No insider trading patterns or beneficial ownership changes mentioned.
Katapult Holdings, Inc. 8-K neutral materiality 7/10

18-06-2026

Katapult Holdings, Inc. and its merger subsidiaries entered into a First Amendment to the existing Agreement and Plan of Merger with CCF Holdings LLC and Aaron’s Intermediate Holdco, Inc. The amendment expands the post-closing Katapult Board from nine to ten members and updates the slate of directors, adding Orlando Zayas contingent on the closing occurring after the 2026 Annual Meeting. No financial terms were disclosed.

  • · The Amendment was executed on June 17, 2026, amending the original Merger Agreement dated December 11, 2025.
  • · The only substantive changes are to the board composition and director nominees, as described in Section 2.
Chicago Atlantic BDC, Inc. 8-K positive materiality 9/10

18-06-2026

Chicago Atlantic Real Estate Finance, Inc. (REFI) and Chicago Atlantic BDC, Inc. (LIEN) have entered into a definitive merger agreement under which REFI will elect to be regulated as a BDC and merge with and into LIEN in an all-stock, strategic combination. The merger creates a pro-forma NAV of $613 million and a pro-forma investment portfolio of $771 million, with former REFI stockholders expected to own approximately 50.5% of the combined entity. The merger is subject to stockholder approvals from both companies and regulatory clearances, with a target closing in the fourth quarter of 2026; however, execution risk remains given the conditions and the fact that the actual ownership split will depend on NAV calculations close to closing.

  • · LIEN will survive as the public entity and continue trading under ticker 'LIEN' on Nasdaq.
  • · The merger is structured as an adjusted NAV-for-NAV exchange of shares; the exchange ratio will be determined shortly before closing.
  • · Closing is expected in the fourth quarter of 2026, subject to stockholder votes (both companies), regulatory approvals, lender consents, and other customary conditions.
  • · The combined company's pro-forma portfolio credit metrics are described as strong, reflecting aligned investment and underwriting philosophies.
  • · The LIEN board will consider adopting a stock repurchase program of up to $25.0 million post-closing.
  • · Chicago Atlantic has committed to fund $2.0 million of REFI's transaction-related expenses.
  • · Advisers: Oppenheimer & Co. and Keefe, Bruyette & Woods (KBW) served as financial advisors; Nixon Peabody and Eversheds Sutherland as legal counsel.
DELUXE CORP 8-K mixed materiality 8/10

18-06-2026

Deluxe Corp (DLX) announced the acquisition of Celero Commerce for $625M in cash, funded through debt financing, to accelerate its revenue mix shift toward higher-growth Payments and Data segments. The deal is expected to be accretive to adjusted EPS in the first year post-closing, with over $15M in anticipated cost synergies by 2028, and Deluxe reaffirms its 2026 full-year guidance (excluding Celero). However, the transaction will increase Deluxe's net leverage to approximately 3.9x at closing, with a plan to reduce it below 3.0x within 24 months, and the combined Payments and Data businesses are projected to rise to 57% of 2026 proforma revenues (up from 31% in 2020).

  • · Deluxe expects to close the transaction in Q3 2026, subject to regulatory approvals and customary conditions.
  • · The acquisition will be funded via $375M incremental Term Loan A from a five-bank syndicate led by BofA Securities and drawing on Deluxe's existing revolving credit facility.
  • · Deluxe reaffirms its 2026 full-year guidance (excluding Celero) and will provide updated guidance post-closing.
  • · Celero processed approximately $70B in combined gross transaction volume with Deluxe in 2025, making the combined entity one of the 10 largest non-bank merchant acquirers in the US.
  • · Celero added approximately 60 new partners in 2025 from an active base of 375 partners.
  • · No change required to Deluxe's dividend policy.
  • · Investor conference call scheduled for June 18, 2026 at 8:30 a.m. ET (passcode: 502756).
Chicago Atlantic Real Estate Finance, Inc. 8-K mixed materiality 9/10

18-06-2026

Chicago Atlantic Real Estate Finance, Inc. (REFI) and Chicago Atlantic BDC, Inc. (LIEN) announced a definitive all-stock merger agreement under which REFI will elect to be regulated as a BDC and merge into LIEN, with LIEN as the surviving entity. The pro-forma combined entity has a NAV of $613M and a portfolio of $771M, with former REFI stockholders expected to own approximately 50.5% of LIEN. The merger is expected to close in Q4 2026, subject to stockholder and regulatory approvals, and includes a potential $25M stock repurchase program by LIEN's board.

  • · The merger is structured as an adjusted NAV-for-NAV exchange of shares.
  • · The actual ownership percentage for former REFI stockholders will depend on the NAV ratio calculated shortly prior to closing.
  • · The merger is expected to close in Q4 2026.
  • · Chicago Atlantic has agreed to fund $2.0 million of REFI's transaction-related expenses.
  • · A joint conference call was held on June 18, 2026 at 9:00 a.m. ET.
  • · The combined company will trade on the Nasdaq Global Select Market under the ticker 'LIEN'.
  • · The merger is subject to stockholder approvals of both REFI and LIEN, regulatory approvals, lender consents, and other customary closing conditions.
  • · The LIEN board will consider in good faith the adoption of a stock repurchase program of up to $25.0 million post-closing.
  • · The pro-forma portfolio includes a mix of cash-flow loans, real estate-backed loans, and diversified direct lending.
  • · The merger is intended to create a scaled BDC positioned for growth while maintaining industry leading credit quality and portfolio yield.
JANUS HENDERSON GROUP PLC 8-K positive materiality 9/10

18-06-2026

Janus Henderson Group plc (JHG) has received all required regulatory approvals and client consents to proceed with its take-private transaction by Trian Fund Management and General Catalyst, following overwhelming shareholder approval. The transaction is expected to close on June 30, 2026, with shareholders receiving $52.00 per share in cash, after which the company will be delisted from the NYSE and become privately held. As of March 31, 2026, Janus Henderson reported approximately $480 billion in assets under management and over 2,000 employees.

  • · The transaction was originally announced via a definitive agreement dated December 21, 2025, which was subsequently amended.
  • · Shareholder approval was described as 'resounding'.
  • · The closing is subject to continued satisfaction of all conditions under the definitive agreement.
  • · Janus Henderson had offices in 26 cities worldwide as of March 31, 2026.
  • · The company helps millions of people globally invest in a brighter future together.
IIOT-OXYS, Inc. 8-K neutral materiality 5/10

18-06-2026

IIOT-OXYS, Inc. entered into Amendment No. 1 to its Securities Purchase Agreement with GHS Investments, LLC on June 12, 2026, authorizing up to 167 shares of Series D Convertible Preferred Stock in aggregate. The amendment adds two additional closings: a Second Additional Closing for up to 40 shares (37 purchased at $37,000 plus 3 equity incentive shares) and a Third Additional Closing for up to 30 shares (27 purchased at $27,000 plus 3 equity incentive shares), each at GHS's discretion. On June 16, 2026, the Company issued 30 shares of Series D Convertible Preferred Stock to GHS under the Third Additional Closing, receiving $27,000 in cash. The offering was conducted as a private placement under Section 4(a)(2) and Rule 506(b) of Regulation D, with GHS representing itself as an accredited investor.

  • · The original SPA dated March 6, 2026 provided for an Initial Closing of 47 shares (43 purchased + 4 equity) and one Additional Closing of 50 shares (45 purchased + 5 equity), for an aggregate of 97 shares.
  • · Amendment No. 1 increases the aggregate authorized shares from 97 to 167.
  • · The Third Additional Closing occurred on June 16, 2026, with the Company issuing 30 shares to GHS for $27,000.
  • · The securities were issued in reliance on Section 4(a)(2) and Rule 506(b) of Regulation D, with no general solicitation.
  • · GHS Investments, LLC is a Nevada limited liability company and represented itself as an accredited investor.
SS Innovations International, Inc. 8-K neutral materiality 7/10

18-06-2026

SS Innovations International, Inc. entered into an ATM Sales Agreement with Virtu Americas LLC on June 18, 2026, to sell up to $50 million of its common stock through an at-the-market offering program. The company filed a prospectus supplement under its existing shelf registration statement (Form S-3, File No. 333-295501) and will pay Virtu a commission of up to 3.0% of gross proceeds. The filing does not disclose any prior-period financial data, so no period-over-period comparisons are available.

  • · The ATM Sales Agreement was executed on June 18, 2026, and the prospectus supplement was filed the same day.
  • · The shelf registration statement (Form S-3, File No. 333-295501) was originally filed on May 1, 2026, and declared effective on May 18, 2026.
  • · Virtu Americas LLC will act as exclusive sales agent or principal, using commercially reasonable efforts consistent with its normal trading and sales practices.
  • · The company agreed to reimburse Virtu for certain specified expenses, but this obligation is waived if the company sells enough shares to raise a certain amount of gross proceeds on or before the first anniversary of the agreement.
  • · The Sales Agreement contains customary representations, warranties, and covenants, and the company agreed to indemnify Virtu against certain liabilities, including under the Securities Act.
  • · The legal opinion of Lewis Brisbois Bisgaard & Smith LLP is filed as Exhibit 5.1.
Vireo Growth Inc. 8-K mixed materiality 8/10

18-06-2026

Vireo Growth Inc. announced a definitive arrangement agreement to acquire all outstanding shares of C21 Investments Inc. in an all-stock transaction, with C21 shareholders receiving 0.023052 Vireo shares per C21 share. The acquisition is expected to expand Vireo's Nevada presence to approximately 15 dispensaries and 158,000 square feet of cultivation and manufacturing capacity, while adding C21's high-volume Silver State Relief brand. However, the transaction is subject to shareholder and regulatory approvals, and C21 will pay a US$3 million termination fee if it accepts a superior proposal, indicating potential deal risk.

  • · The Exchange Ratio is 0.023052 Vireo subordinate voting shares per C21 common share.
  • · The C21 Board formed a Special Committee to evaluate the transaction, which unanimously recommended approval.
  • · Needham & Company, LLC provided a fairness opinion to the C21 Board.
  • · The transaction requires approval of at least two-thirds of C21 shareholder votes cast, and a simple majority of minority shareholders if required under MI 61-101.
  • · Certain directors and executive officers of C21 have entered into Voting Support Agreements to vote their shares in favor of the transaction.
  • · The C21 Meeting is expected to be held in the third quarter of 2026.
  • · The Arrangement Agreement includes non-solicitation covenants, a fiduciary out, and a right to match provision for C21.
  • · The termination fee payable by C21 to Vireo is US$3,000,000.
  • · The securities issued in the transaction will be exempt from U.S. Securities Act registration under Section 3(a)(10).
  • · C21 owns legacy Oregon brands Phantom Farms, Hood Oil, and Eco Firma Farms.
Silvercrest Asset Management Group Inc. 8-K neutral materiality 5/10

18-06-2026

Silvercrest Asset Management Group Inc. (SAMG) entered into a Second Amendment to its credit agreement with City National Bank on June 18, 2026. The amendment extends the term loan maturity to June 18, 2029 (with two one-year extension options), sets the term loan commitment at $5.0 million, and extends the $10.0 million revolving credit facility maturity to June 18, 2027. The term loan draw date is now June 18, 2028.

  • · The Second Amendment was entered into by subsidiaries of Silvercrest L.P. as borrowers, with Silvercrest L.P. acting as guarantor.
  • · The term loan maturity date is June 18, 2029, with two one-year extension options available.
  • · The term loan draw date terminates on June 18, 2028.
  • · The revolving credit facility maturity date is June 18, 2027.
Bandwidth Inc. 8-K neutral materiality 7/10

18-06-2026

Bandwidth Inc. entered into a capped call option transaction with a dealer on June 18, 2026, in connection with its issuance of $[amount]% Convertible Senior Notes due 2032. The transaction is designed to reduce potential dilution upon conversion of the notes, with the dealer selling call options to Bandwidth. The filing details the terms of the ISDA Master Agreement and equity derivative definitions governing the transaction.

  • · The transaction is governed by a 2002 ISDA Master Agreement with the laws of the State of New York as governing law.
  • · The capped call transaction covers both Base Convertible Securities and Optional Convertible Securities issued under the offering.
  • · The Free Convertibility Date is April 1, 2032, and the Expiration Date is July 1, 2032.
  • · The Number of Options is based on the principal amount of Convertible Securities in denominations of USD 1,000.
  • · The Strike Price and Cap Price are to be determined and inserted into the confirmation.
Limoneira CO 8-K negative materiality 6/10

18-06-2026

Limoneira Company (LMNR) announced on June 18, 2026 that its subsidiary, Windfall Investors, LLC, received a termination notice from Peak Holdings, LLC regarding the Purchase and Sale Agreement for an 80% tenant-in-common interest in the Company's real estate parcels in Paso Robles, California. The $500,000 deposit held in escrow will be returned to Peak Holdings, and the termination is effective as of June 15, 2026.

  • · The Purchase and Sale Agreement was originally dated April 14, 2026.
  • · The termination notice was received by Windfall Investors, LLC on June 15, 2026.
  • · The termination is pursuant to Section 5.5 of the Purchase Agreement, which allows termination during the due diligence review period.
  • · The real estate parcels are located in Paso Robles, California.
  • · The 80% interest was an undivided tenant-in-common interest.
MARTEN TRANSPORT LTD 8-K neutral materiality 5/10

18-06-2026

Marten Transport Ltd. entered into a First Amendment to its Credit Agreement with U.S. Bank National Association, increasing the Letter of Credit Sublimit from $30,000,000 to $35,000,000 and raising the maximum aggregate revolving commitment and incremental term loan facility from $100,000,000 to $105,000,000. The amendment also updates compliance representations regarding anti-corruption laws and sanctions. The company reaffirmed its obligations and released the bank from any prior claims, while guarantor subsidiaries confirmed their guarantees remain in full force.

  • · The amendment was executed on June 12, 2026, and filed on June 18, 2026.
  • · The prior Revolving Note of $30,000,000 is replaced but not novated; all existing indebtedness and collateral continue.
  • · The amendment includes a release by the borrower of any claims against the bank and agent arising prior to the amendment date.
  • · Guarantor subsidiaries (Marten Transport Services, Ltd., Marten Transport Logistics, LLC, Marten Transport Holdings, Ltd.) acknowledged and confirmed their guarantees remain in effect.
  • · The credit agreement is governed by Minnesota law, with consent to jurisdiction and waiver of jury trial.
MSP Recovery, Inc. 8-K mixed materiality 6/10

18-06-2026

MSP Recovery, Inc. (MSPRZ) entered into a letter agreement with Hazel Partners Holdings LLC on June 11, 2026, confirming a total of $8,147,500 in Operational Collection Floor increases funded between March 2025 and May 2026, plus an additional $550,000 for legal expenses. The agreement also notes an additional $69,000 funding requested and Hazel's willingness to provide it, bringing the aggregate to $8,147,500. However, the funding is at the sole discretion of the lender, and the company remains dependent on continued lender support, with no guarantee of further increases.

  • · The funding tranches ranged from $49,687 to $1,750,000, with the largest single tranche ($1,750,000) funded on March 3, 2025.
  • · The HC Case Proceeds of approximately $1,300,000 are from property and casualty litigation, with 50% due to Assignor and 50% to Assignee.
  • · The $69,000 additional funding is conditioned on no Event of Default or Default occurring after the borrowing.
  • · The Administrative Agent reserves all rights under the Credit Agreement and may refuse further funding at its sole discretion.
UNITED RENTALS, INC. 8-K neutral materiality 5/10

18-06-2026

United Rentals, Inc. entered into Amendment No. 18 to its Third Amended and Restated Receivables Purchase Agreement on June 18, 2026, extending the Facility Termination Date and making other amendments. The amendment was executed by the originator, seller, collection agent, multiple purchasers (Liberty Street Funding, Gotham Funding, GTA Funding, Reliant Trust), banks, and purchaser agents. No financial terms or specific changes in credit limits were disclosed beyond a one-time fee of 5 basis points on each bank’s commitment.

  • · The amendment extends the Facility Termination Date under both the Purchase Agreement and the Contribution Agreement.
  • · Each Purchaser Agent received a one-time upfront fee of 5 basis points on its related Bank's Bank Commitment.
  • · The amendment includes replacing Annex E to the Purchase Agreement with a new Annex E.
  • · Legal opinions on true sale and non-consolidation matters were provided by Troutman Pepper Locke LLP.
LIXTE BIOTECHNOLOGY HOLDINGS, INC. 8-K mixed materiality 8/10

18-06-2026

LIXTE Biotechnology Holdings, Inc. announced an update on its acquisition of NOMAD Transportable Power Systems, expected to close on or about July 1, 2026. To accelerate NOMAD's commercial momentum, LIXTE will loan $6.5 million pre-closing to fund order backlog and working capital. Post-closing, the combined company will be renamed NOMAD Power Solutions, Inc. and trade under a new ticker symbol, reflecting a strategic pivot from clinical-stage biotech to utility-grade battery energy storage. However, the acquisition is subject to customary closing conditions and approvals, and LIXTE's existing biotech operations face inherent clinical and regulatory risks.

  • · NOMAD is described as the market leader in deployable, utility-grade battery energy storage systems (BESS) and the first to bring a mobile, utility-grade 1 MW BESS to market.
  • · The NOMAD platform is UL 9540-validated and serves utilities, industrial operators, government agencies, critical infrastructure providers, and AI-driven applications.
  • · LIXTE's existing biotech pipeline includes proof-of-concept clinical trials for Ovarian Clear Cell Carcinoma, Metastatic Colon Cancer, and Advanced Soft Tissue Sarcoma.
  • · LIXTE's wholly owned subsidiary Liora Technologies Europe Ltd. is developing electronically controlled proton therapy systems (LiGHT System).
  • · The new ticker symbol for the combined company is to be announced.
Hyperscale Data, Inc. 8-K mixed materiality 8/10

18-06-2026

Hyperscale Data, Inc. (GPUS) announced an at-the-market equity offering program to sell up to $300 million of common stock through Spartan Capital Securities. The company intends to use the majority of net proceeds to develop its Michigan and Montana data facilities, acquire more Bitcoin, and purchase precious metals, while a smaller portion will be used for working capital and general corporate purposes. The filing also notes the planned divestiture of its subsidiary Ault Capital Group (ACG) in Q2 2027, which will transform the company into a pure-play data center and digital asset holder.

  • · The offering is made under a shelf registration statement (File No. 333-291595) effective December 11, 2025.
  • · Sales may be made through ordinary brokers' transactions on NYSE American at prevailing market prices.
  • · Management has broad discretion over the use of net proceeds, including potential repayment of future indebtedness or capital stock.
  • · The company issued 1,000,000 shares of Series F Preferred Stock to all common and Series C Preferred stockholders on an as-converted basis on December 23, 2024.
  • · The divestiture of ACG will occur through a voluntary exchange of Series F Preferred Stock for ACG shares.
  • · Hyperscale Data's headquarters are at 11411 Southern Highlands Parkway, Suite 190, Las Vegas, NV 89141.
BrightView Holdings, Inc. 8-K positive materiality 7/10

18-06-2026

BrightView Holdings, Inc. announced the successful extension of its senior secured term loan maturity from April 2029 to June 2033 and its receivables financing facility from June 2027 to June 2029. CFO Brett Urban highlighted strong lender demand and confidence in the company's One BrightView strategy and progress toward 2030 objectives. The extensions enhance balance sheet flexibility and provide additional runway for strategic priorities, with no negative or flat metrics reported.

  • · Term loan maturity extended from April 2029 to June 2033 (4-year extension).
  • · Receivables financing facility maturity extended from June 2027 to June 2029 (2-year extension).
  • · BrightView is the nation's largest commercial landscaper and serves as Field Consultant to Major League Baseball.
WHIRLPOOL CORP /DE/ 8-K neutral materiality 5/10

18-06-2026

Whirlpool Corporation, via its subsidiary Whirlpool Finance Luxembourg S.à r.l., entered into a First Supplemental Indenture on June 18, 2026, to amend the terms of its 1.100% Notes due 2027. The amendment accelerates the issuer's ability to satisfy and discharge the indenture by reducing the required waiting period from one year to two years. The change was approved by holders of approximately 91.12% of the outstanding notes (€546,715,000 aggregate principal) tendered in a consent solicitation.

  • · The First Supplemental Indenture amends Section 10.01 of the original Indenture, replacing 'one year' with 'two years' for satisfaction and discharge.
  • · The amendment becomes operative once all tendered 2027 Notes are purchased at the expiration of the Tender Offer.
  • · The filing includes no new financial statements; only the supplemental indenture and cover page interactive data file are attached as exhibits.
PTC THERAPEUTICS, INC. 8-K neutral materiality 5/10

18-06-2026

PTC Therapeutics, Inc. filed an 8-K on June 18, 2026, disclosing entry into a material agreement and related matters. The filing includes forward-looking statements regarding the repurchase of existing convertible notes, but no specific financial figures or performance metrics were provided.

  • · The filing covers Items 1.01, 2.03, 3.02, 8.01, and 9.01, indicating entry into a material agreement, incurrence of debt, and other material events.
  • · The company specifically disclaims any obligation to update forward-looking statements after the filing date.
Seadrill Ltd 8-K neutral materiality 6/10

18-06-2026

Seadrill Ltd entered into Amendment No. 2 to its Senior Secured Revolving Credit Agreement, refinancing its existing revolving commitments with a new $300 million tranche (2026 Revolving Commitments) and replacing J.P. Morgan SE with JPMorgan Chase Bank, N.A. as administrative agent. The amendment, effective June 16, 2026, maintains the existing credit facility structure while updating lender commitments and agent roles.

  • · The amendment refinances and permanently replaces existing revolving commitments on a dollar-for-dollar basis.
  • · J.P. Morgan SE resigned as administrative agent, and JPMorgan Chase Bank, N.A. was appointed as successor administrative agent effective as of the Agency Effective Time.
  • · The amendment updates several schedules and exhibits to the credit agreement, including Schedules 1.1(c), 1.1(e), 2.12(a), 5.20, and 5.21.
  • · The 2026 Revolving Lenders are identified on Schedule 1 to the amendment, with each lender's commitment amount specified.
  • · Outstanding letters of credit as of the effective date will be deemed outstanding under the new 2026 Revolving Commitments, with lenders holding participations pro rata.
Viatris Inc 8-K neutral materiality 7/10

18-06-2026

Viatris Inc. completed a public offering of €650 million aggregate principal amount of 4.250% Senior Notes due 2033 on June 17, 2026. The net proceeds will be used primarily to fund the repayment of $1.675 billion of outstanding 3.950% Senior Notes due 2026 issued by Utah Acquisition Sub Inc., with any remainder for general corporate purposes. The new notes are senior unsecured obligations guaranteed by Mylan Inc., Mylan II B.V., and Utah Acquisition Sub Inc.

  • · The Notes were issued under a Registration Statement on Form S-3 (File No. 333-287087).
  • · Interest on the Notes accrues from June 17, 2026, payable annually beginning June 17, 2027, with maturity on June 17, 2033.
  • · The Company may redeem the Notes at any time prior to April 17, 2033 (Par Call Date) at the greater of 100% of principal or discounted present value plus 25 basis points; on or after the Par Call Date at 100% of principal plus accrued interest.
  • · Upon a change of control, the Company must offer to repurchase the Notes at 101% of principal plus accrued interest.
  • · The Indenture includes covenants restricting sale and leaseback transactions, creation of liens, subsidiary guarantees, and mergers/asset sales.
  • · Customary events of default include nonpayment, breach of covenants, payment defaults on other indebtedness, failure to pay certain judgments, and bankruptcy/insolvency.
Construction Partners, Inc. 8-K positive materiality 8/10

18-06-2026

Construction Partners, Inc. entered into Amendment No. 1 to its Term Loan B Credit Agreement on June 18, 2026, refinancing all outstanding term loans and adding $300.0 million in incremental term loans, increasing total term loan principal from $839.4 million to $1,139.4 million. The amendment reduces interest rate margins by 0.25% per annum if the consolidated first lien net leverage ratio falls below 2.95-to-1.00, and modifies covenants to allow up to $50.0 million per fiscal year in stock repurchases and additional flexibility for capital structure management. The maturity date remains November 1, 2031, with quarterly amortization of 0.25% of the aggregate principal.

  • · The TLB Amendment resets a six-month repricing protection period with a 1.00% prepayment premium for certain repricing transactions.
  • · Incurrence-based leverage ratio tests for incremental debt capacity, excess cash flow sweep, and certain negative covenants were increased by 0.25 to 1.00.
  • · The amendment permits liquidation or dissolution of Immaterial Subsidiaries subject to conditions.
  • · A floor of $325.0 million was added to the existing 50% of Consolidated Adjusted EBITDA limit on Qualifying Cash for net leverage ratio calculation.
  • · Prior to the first quarterly testing date on September 30, 2026, the Applicable Margin remains at Level 1 Pricing.
Epsilon Energy Ltd. 8-K neutral materiality 7/10

18-06-2026

Epsilon Energy Ltd. entered into a Sales Agreement with Roth Capital Partners, LLC on June 18, 2026, allowing the company to sell up to $15,000,000 of its common shares in 'at the market' offerings. The agreement provides flexibility for the company to raise capital at prevailing market prices, with Roth Capital receiving a 3.0% commission on gross proceeds. However, there is no obligation to sell any shares, and no assurance can be given regarding the price, amount, or timing of any sales.

  • · The Sales Agreement was filed as Exhibit 10.1 to the 8-K.
  • · A legal opinion from McLeod Law LLP regarding the validity of the shares was filed as Exhibit 5.1.
  • · The shares will be issued under the company's existing shelf registration statement on Form S-3 (File No. 333-292704), effective January 22, 2026.
  • · The company may terminate the Sales Agreement at any time as provided in the agreement.
Exeter Automobile Receivables Trust 2026-3 8-K mixed materiality 8/10

18-06-2026

Exeter Automobile Receivables Trust 2026-3 filed an 8-K on June 18, 2026, announcing the issuance of eight classes of asset-backed notes totaling approximately $1.292 billion, secured by sub-prime auto loan receivables. The offering includes senior notes (Classes A-1 through A-3) with coupons ranging from 4.046% to 4.47%, and subordinate notes (Classes B through E and Class N) with higher coupons from 4.70% to 7.42%. The trust will enter into multiple agreements on the closing date (June 24, 2026) to transfer and service the receivables, with an underwriting agreement signed on June 16, 2026, with Wells Fargo, Barclays, and J.P. Morgan as representatives.

  • · The trust will issue notes in eight classes with total principal of approximately $1.292 billion.
  • · The underwriting agreement was signed on June 16, 2026, with Wells Fargo, Barclays, and J.P. Morgan as representatives.
  • · The closing date for the note issuance is on or about June 24, 2026.
  • · The underlying assets are sub-prime automobile loan contracts (Receivables) transferred from Exeter to EFCAR.
  • · The offering includes a Class N note with a 6.66% coupon, the highest among the classes.
  • · The Class E note has a 7.42% coupon, the second highest.
  • · The Class A-1 note has the lowest coupon at 4.046%.
  • · The trust will enter into multiple agreements including a Sale and Servicing Agreement, Indenture, and Custodian Agreement on the closing date.
  • · The filing includes certifications by the CEO of EFCAR as required by Form SF-3.
NextDecade Corp 8-K neutral materiality 8/10

18-06-2026

NextDecade Corp's indirect subsidiary, Rio Grande LNG Intermediate HoldCo Borrower, entered into a $1.0 billion term loan credit agreement on June 17, 2026, with proceeds primarily used to reduce outstanding borrowings under RGLNG's credit facilities. The loan carries a 7.05% annual interest rate, matures on June 17, 2033, and includes interest paid in-kind for the first three years unless cash is elected. The agreement imposes customary covenants, including a debt service coverage ratio of at least 1.05:1.00, and prepayment penalties apply before June 17, 2030.

  • · Interest on the RGLNG HoldCo Loans is payable semi-annually on March 30 and September 30, beginning September 30, 2026.
  • · Interest is paid in-kind until the first interest payment date after the third anniversary of the Closing Date (June 17, 2026) unless RGLNG HoldCo Borrower elects cash payment.
  • · Prepayment is allowed at any time before June 17, 2029 with a call protection amount; between June 17, 2029 and June 17, 2030 at 101% of principal; on or after June 17, 2030 at par.
  • · Mandatory prepayment at 101% upon a change of control event; mandatory prepayment at par for proceeds from asset sales, events of loss, or liquidated damages.
  • · The Credit Agreement limits RGLNG HoldCo Borrower's ability to incur additional indebtedness, make investments, pay dividends, sell assets, incur liens, or merge.
  • · Security interests were granted by RGLNG HoldCo Pledgor in the LLC interests of RGLNG HoldCo Borrower and by RGLNG HoldCo Borrower in substantially all its real and personal property, including its membership interest in Rio Grande LNG Holdings, LLC.
  • · A Collateral and Intercreditor Agreement governs relationships among HoldCo Lenders and any future pari passu indebtedness holders.
Algorhythm Holdings, Inc. 8-K negative materiality 8/10

18-06-2026

Algorhythm Holdings, Inc. (RIME) received a Nasdaq deficiency notice on June 16, 2026, for failing to maintain a minimum bid price of $1.00 per share over 30 consecutive business days. The company has a 180-day compliance period until December 14, 2026, to regain compliance, with a possible additional 180-day extension if certain conditions are met. The company is considering options including a reverse stock split, but there is no assurance of regaining compliance.

  • · The deficiency notice was based on the closing bid price from May 4, 2026 to June 15, 2026.
  • · If compliance is not regained in the initial 180-day period, the company may be eligible for an additional 180-day compliance period if it meets other listing standards and provides written notice of intent to cure, including via reverse stock split.
  • · The notification has no immediate effect on trading; RIME continues to trade on Nasdaq during the compliance period.
Tianci International, Inc. 8-K mixed materiality 7/10

18-06-2026

Tianci International, Inc. (CIIT) announced the pricing of a $4.9 million registered public offering of 6,055,000 units at $0.81 per unit, with each unit consisting of one share of common stock (or pre-funded warrant) and one common warrant. The offering is expected to close on June 17, 2026, with net proceeds used for working capital and general corporate purposes. The company operates an asset-light ocean freight forwarding model and has diversified into mineral trading, electronic parts sales, and business consulting, but faces dilution risk from the new shares and warrants.

  • · The offering is on a best efforts basis, not firm commitment.
  • · Each Common Warrant is exercisable immediately at $0.81 per share and expires on the third anniversary of issuance.
  • · The registration statement (Form S-1, File No. 333-296417) was declared effective by the SEC on June 15, 2026.
  • · The company operates under an asset-light model through its subsidiary Roshing, serving the Asia-Pacific region including Japan, South Korea, and Vietnam.
  • · No period-over-period financial comparisons are provided in this filing.
Cantor Equity Partners VII, Inc. 8-K positive materiality 8/10

18-06-2026

Cantor Equity Partners VII, Inc. (Nasdaq: CAES) priced its initial public offering of 25,000,000 Class A ordinary shares at $10.00 per share, raising $250 million. The shares began trading on the Nasdaq Global Market on June 17, 2026, and the offering is expected to close on June 18, 2026. The company is a blank check company sponsored by Cantor Fitzgerald, focusing on targets in financial services, digital assets, healthcare, real estate services, technology, software, and energy industries.

  • · The underwriters have a 45-day option to purchase up to an additional 3,750,000 shares to cover over-allotments.
  • · Cantor Fitzgerald & Co. is the sole book-running manager for the offering.
  • · The company is a blank check company with no specific target industry, but intends to focus on financial services, digital assets, healthcare, real estate services, technology, software, and energy.
  • · The registration statement was declared effective by the SEC on June 16, 2026.
  • · Media contact: Danielle Popper, danielle.popper@cantor.com, +1 212-938-5000.
bioAffinity Technologies, Inc. 8-K mixed materiality 7/10

18-06-2026

bioAffinity Technologies, Inc. announced the pricing of a $3.2 million public offering of 4,000,000 shares of common stock (or pre-funded warrants in lieu thereof) at $0.80 per share, with closing expected on June 18, 2026. The offering is intended to raise gross proceeds before expenses, but the company does not report any new operational milestones or financial performance metrics, and the dilutive impact on existing shareholders is notable given the low share price.

  • · The offering price per share is $0.80, and pre-funded warrants are priced at $0.793 each.
  • · Each pre-funded warrant is exercisable for one share of common stock, immediately exercisable, and expires when exercised in full.
  • · The offering is made under a registration statement on Form S-1 (File No. 333-296764), previously declared effective by the SEC.
  • · WallachBeth Capital, LLC is acting as sole placement agent.
  • · CyPath® Lung is a noninvasive test for early detection of lung cancer, using flow cytometry and AI, with published clinical trial results showing 92% sensitivity, 87% specificity, 88% accuracy, and 99% negative predictive value in high-risk patients with small indeterminate lung nodules (<20 mm).
  • · The company does not disclose any new financial results, revenue, or operational updates beyond the offering.
UNIVERSAL INSURANCE HOLDINGS, INC. 8-K neutral materiality 7/10

18-06-2026

Universal Insurance Holdings, Inc. (UVE) entered into a Note Purchase Agreement on June 16, 2026, to issue and sell up to $100 million aggregate principal amount of 7.75% Senior Unsecured Notes due 2031 in a private placement to qualified institutional buyers and institutional accredited investors. The notes will be issued under an indenture with UMB Bank National Association as trustee, and Piper Sandler & Co. is acting as exclusive placement agent. The offering includes registration rights for resale of the notes.

  • · The notes are being sold in a private placement exempt from registration under Section 4(a)(2) of the Securities Act, solely to QIBs (Rule 144A) and Institutional Accredited Investors with at least $5 million in total assets.
  • · The Issuer will enter into a Registration Rights Agreement to file a shelf registration statement with the SEC for resale of the notes.
  • · The notes are senior unsecured obligations of the Issuer, due in 2031.
  • · The offering is concurrent with sales to other purchasers under substantially similar purchase agreements.
  • · The Issuer represents it is not required to register as an investment company after the sale.
  • · No period-over-period comparisons are available in this filing.
CENTRUS ENERGY CORP 8-K neutral materiality 5/10

18-06-2026

Centrus Energy Corp. announced that at its 2026 annual meeting on June 18, 2026, stockholders approved the seventh amendment to its Section 382 Rights Agreement, extending the plan through June 30, 2029. The Rights Plan is designed to preserve the company's substantial tax assets, specifically net operating loss carryforwards (NOLs), by preventing an ownership change that could limit their use under Section 382 of the Internal Revenue Code. This extension ensures continued protection of these valuable tax assets, but no financial figures or performance metrics were disclosed in the filing.

  • · The Rights Plan extension runs through June 30, 2029.
  • · An ownership change under Section 382 occurs if 5% stockholders' ownership increases by more than 50% over the lowest percentage owned in the prior three years on a rolling basis.
  • · Centrus has supplied fuel equivalent to more than 7 billion tons of coal since 1998.
Volato Group, Inc. 8-K neutral materiality 6/10

18-06-2026

Volato Group, Inc. closed a private placement on June 18, 2026, issuing 6,500,000 shares of Class A common stock at $0.34 per share, generating gross proceeds of approximately $2.21 million. The company also amended its Registration Rights Agreement to extend the filing deadline for the resale registration statement to 5:30 p.m. ET on the same day. The offering was conducted under exemptions from registration, and the shares have not been registered under the Securities Act.

  • · The shares were issued at $0.34 per share.
  • · The offering was conducted under exemptions from registration provided by Section 4(a)(2) of the Securities Act and Regulation D.
  • · The shares have not been registered under the Securities Act and may not be offered or sold in the U.S. without registration or an applicable exemption.
  • · The company is an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.
Nuvve Holding Corp. 8-K negative materiality 8/10

18-06-2026

Nuvve Holding Corp. entered into a $1.5M term loan agreement with ACH Capital West, LLC on June 12, 2026, with principal and $585,000 interest due May 11, 2027. The loan requires weekly payments of $43,437.50 starting June 19, 2026, and includes a $45,000 origination fee. Early repayment incentives reduce the total repayment by up to $210,000 if repaid within 30 days, while a 25% default fee applies on non-payment.

  • · The loan matures on May 11, 2027.
  • · Weekly payments of $43,437.50 commence June 19, 2026.
  • · The Company granted a continuing security interest in all amounts owing and all tangible/intangible personal property.
  • · Default events include non-payment, covenant breaches, insolvency, bankruptcy, and material adverse effect.
  • · Upon default, the Lender may accelerate all obligations and terminate commitments.
  • · The full agreement will be filed with the Company's Quarterly Report on Form 10-Q for the quarter ending June 30, 2026.
Honest Company, Inc. 8-K mixed materiality 7/10

18-06-2026

Honest Company, Inc. (HNST) entered into a 10-year office lease for 38,240 RSF on the 5th floor of The Bluffs in Playa Vista, CA, with a commencement date no earlier than March 1, 2027. The lease includes escalating annual base rent from $1.61M in Year 1 to $4.23M in Year 10, a $1.2M letter of credit requirement, and a $180/RSF tenant improvement allowance. However, the rent jumps sharply in Year 3 (from $1.72M to $3.33M, a 93% increase), and the long-term commitment represents a significant fixed cost obligation.

  • · Lease commencement date is the later of March 1, 2027 or substantial completion of tenant improvements.
  • · Lease expiration is the last day of the 120th full month after commencement.
  • · Tenant has one 5-year extension option.
  • · Base year for operating expenses is calendar year 2027.
  • · Tenant's share of the building is approximately 15.688%.
  • · Permitted use is general office and administrative uses consistent with a first-class office building in West Los Angeles.
  • · Parking: up to 153 unreserved passes, with 25% convertible to reserved spaces; up to 2 reserved spaces with EV charging at tenant's cost.
  • · Right of first refusal applies only to the original tenant (or an affiliate) occupying at least 50% of the then-existing premises.
  • · If Refusal Space is leased after the 7th lease year and the proposed term extends more than 2 years beyond the initial expiration, the lease expiration date is extended accordingly.
  • · Letter of credit is subject to reduction per Article 21.
Rumble Inc. 8-K neutral materiality 8/10

18-06-2026

Rumble Inc. subsidiary Rumble Freedom First Holding Limited entered into a loan agreement with Tether Investments, S.A. de C.V. on June 18, 2026, in connection with Rumble's proposed tender offer for Northern Data AG. The loan represents the remaining 50% of the purchase price for the ND Loan transfer, with the other 50% settled via an equity issuance of Rumble Class A common stock at $7.88 per share. The loan matures in five years, bears interest at EURIBOR plus 300 basis points, and includes an exchange option allowing Tether to convert the outstanding amount into Rumble common stock at the greater of $7.88 or the 10-day VWAP after 12 months.

  • · The loan is governed by Irish law and the borrower is an Irish private limited company.
  • · The loan is non-recourse and includes a non-petition clause (Clause 23).
  • · Events of default include insolvency, payment default (15 business day cure), material breach (20 business day cure), and change of control of the borrower by Rumble Inc.
  • · The exchange option allows Tether to convert the entire outstanding loan amount into Rumble Class A common stock at the greater of $7.88 or the 10-day VWAP, with settlement within 10 business days after the exchange option date.
  • · Interest is payable quarterly on March 31, June 30, September 30, and December 31.
  • · The loan facility cannot be reutilized after being drawn.
  • · The purchase price for the ND Loan transfer is equal to the outstanding loan amount plus accrued interest as of the 2025 Amendment Date (June 18, 2026).
  • · No cash will actually be exchanged for the loan drawdown or purchase price settlement; it is a deemed transaction.
Ford Credit Auto Owner Trust 2026-B 8-K neutral materiality 5/10

18-06-2026

Ford Credit Auto Owner Trust 2026-B filed an 8-K on June 18, 2026, reporting the entry into an Underwriting Agreement on June 16, 2026, for the issuance of asset-backed securities (Notes). The filing also includes certifications and final versions of transaction documents. No financial figures or period comparisons are provided.

  • · The Underwriting Agreement was entered into on June 16, 2026, with multiple underwriters.
  • · The Trust will issue asset-backed securities under a Prospectus dated June 16, 2026.
  • · Transaction documents include Indenture, Trust Agreement, Receivables Purchase Agreement, Sale and Servicing Agreement, Administration Agreement, Account Control Agreement, and Asset Representations Review Agreement.
  • · The Depositor's CEO certification for shelf offerings of asset-backed securities is included.
Yorkville International Capital Corp. 8-K neutral materiality 7/10

18-06-2026

Yorkville International Capital Corp., a blank check company, announced the pricing of its $200,000,000 initial public offering of 20,000,000 units at $10.00 per unit, with the units expected to list on Nasdaq under the symbol "YICCU" starting June 16, 2026. The offering includes a 45-day over-allotment option for up to 3,000,000 additional units, and the company intends to focus its search for a business combination target on established businesses in emerging markets, particularly Latin America and Venezuela. No specific target has been selected, and no substantive discussions have occurred.

  • · The registration statement on Form S-1 (333-295912) was declared effective on June 15, 2026.
  • · The offering is expected to close on June 17, 2026, subject to customary closing conditions.
  • · The company is a blank check company incorporated in the Cayman Islands and has not selected any specific business combination target.
  • · The company intends to focus its search on established businesses in emerging markets, with particular emphasis on Latin America and Venezuela.
  • · No fractional warrants will be issued; only whole warrants will trade.
  • · The underwriter has a 45-day option to purchase up to an additional 3,000,000 units to cover over-allotments.
Unicoin Inc. 8-K mixed materiality 8/10

18-06-2026

Unicoin Inc. entered into multiple asset swap agreements on June 15-17, 2026, with 140 R. E. PROPERTIES INC. in the Philippines, exchanging a total of 4,242,049,002 Unicoins (UNCN) for real estate properties valued at $757,801,759 (approximately $0.18 per Unicoin). The swaps are based on seller-provided appraisals, with two properties pending updated appraisals expected by July 2026. However, the reliance on appraisals from 2021-2024 and the pending updates introduce valuation uncertainty, and one property's valuation is based on a bank valuation rather than a licensed appraiser.

  • · Two properties have pending updated appraisals, with sellers expected to provide updated values by July 2026.
  • · One property (4,102,124 Unicoins for $1,025,531) was valued using a bank valuation from September 2021, not a licensed appraiser.
  • · Appraisal dates range from July 2023 to November 2024, with some appraisals over two years old at the time of the swap.
  • · All appraisals were denominated in Philippine Peso and converted to USD using OANDA rates on the appraisal date.
  • · The counterparty for all swaps is 140 R. E. PROPERTIES INC., and the expected future owner of the real estate is TransparentBusiness, Inc.
Jaguar Health, Inc. 8-K neutral materiality 6/10

18-06-2026

Jaguar Health, Inc. entered into an Exchange Agreement with Streeterville Capital, LLC on June 9, 2026, to exchange 3.8 shares of Series Q Perpetual Preferred Stock for 34,798 shares of common stock, with the exchange intended to comply with Section 3(a)(9) of the Securities Act. The transaction involves no new cash consideration to the company, as the preferred shares are being surrendered in exchange for common shares that will be issued free of restrictive legends. The agreement includes a tacking provision that allows the holding period for the exchanged shares to include the original Royalty Interest holding period from August 24, 2022, facilitating potential resale under Rule 144.

  • · The Exchange Agreement is dated June 9, 2026, with an effective date of June 9, 2026.
  • · The exchange involves 3.8 shares of Series Q Preferred Stock for 34,798 shares of Common Stock.
  • · The Exchange Shares are to be delivered via DWAC to Lender's brokerage account by June 10, 2026.
  • · No consideration other than the surrender of Exchanged Preferred Shares is given by Lender.
  • · Lender represents it is not an affiliate of Borrower and has not been for the prior three months.
  • · The holding period for Rule 144 purposes includes the original Royalty Interest holding period from August 24, 2022.
  • · The closing is deemed to occur at the offices of Hansen Black Anderson Ashcraft PLLC in Lehi, Utah.
  • · The agreement includes a provision that the Exchange Shares shall not constitute a novation or satisfaction of the Exchanged Preferred Shares.
FirstCash Holdings, Inc. 8-K neutral materiality 5/10

18-06-2026

FirstCash Holdings, Inc. converted from a Delaware corporation to a Texas corporation on June 18, 2026, filing a new Certificate of Formation. The document outlines governance changes including a classified board structure with three classes of directors, supermajority voting requirements for certain amendments, and limitations on shareholder actions. No financial figures are provided in this filing.

  • · Corporation converted from Delaware to Texas on June 18, 2026.
  • · Authorized capital: 100,000,000 shares total (90M common, 10M preferred), each with $0.01 par value.
  • · Board is classified into three classes with staggered three-year terms (Class I expires 2029, Class II 2027, Class III 2028).
  • · Directors can only be removed for cause by a majority vote of outstanding shares.
  • · Special meetings can only be called by the board, certain officers, or holders of at least 50% of outstanding voting shares.
  • · Shareholder action by written consent requires unanimous consent of all voting shareholders.
  • · Amendment of Article VI (classified board) requires a 66 2/3% supermajority vote.
  • · Corporation elects to be governed by Section 21.419 of the TBOC (likely related to shareholder voting or governance).
  • · Certificate includes provisions for exclusive forum (Designated Tribunal) and jury trial waiver for internal entity claims.
Sensei Biotherapeutics, Inc. 8-K neutral materiality 8/10

18-06-2026

Faeth Therapeutics (formerly Sensei Biotherapeutics) entered into an at-the-market (ATM) sales agreement with TD Securities to sell up to $150M of common stock, with the agent receiving a 3% commission. Concurrently, 24,435.594 shares of Series B Non-Voting Convertible Preferred Stock were automatically converted into 24,435,594 common shares, increasing total common shares outstanding to 25,778,754 as of June 15, 2026. No sales have yet occurred under the ATM program, and the company retains discretion to suspend or terminate the offering.

  • · The company retained the right to suspend or terminate the ATM offering at any time without any obligation to sell shares.
  • · The conversion of Series B Preferred Stock occurred automatically on June 15, 2026, two days before the filing date.
  • · The ATM shares will be sold under an S-3 registration statement filed concurrently on June 18, 2026.
ATMOS ENERGY CORP 8-K positive materiality 7/10

18-06-2026

Atmos Energy Corporation completed a public offering of $700 million aggregate principal amount of 4.750% Senior Notes due 2032 on June 18, 2026, generating net proceeds of approximately $693.9 million after underwriting discount and expenses. The notes are unsecured senior obligations ranking equally with existing and future unsubordinated debt, bearing interest at 4.750% per annum payable semi-annually, and maturing on January 15, 2032. The offering was registered under an existing shelf registration statement.

  • · The offering was registered under the Securities Act of 1933 via Form S-3 (Registration No. 333-283563) and a Prospectus Supplement dated June 15, 2026, filed on June 17, 2026.
  • · The notes were issued under a Base Indenture dated March 26, 2009, with an Officers' Certificate delivered on June 18, 2026.
  • · Interest payments begin on January 15, 2027, and are due semi-annually on January 15 and July 15.
  • · The notes may be redeemed at Atmos Energy's option at any time in whole or in part at redemption prices calculated per the Indenture.
  • · Covenants include restrictions on liens, sale and leaseback transactions, mergers, and asset sales, subject to exceptions.
  • · Events of default include interest payment defaults, covenant breaches, certain payment defaults on other debt, and bankruptcy/insolvency events.
Papaya Growth Opportunity Corp. I 8-K negative materiality 8/10

18-06-2026

Papaya Growth Opportunity Corp. I (SPAC) received a Notice of Termination of its Business Combination Agreement (BCA) with 2744026 Alberta Ltd. on June 12, 2026, citing alleged breaches by the SPAC. The SPAC disputes the termination and reserves all rights, but the deal's collapse introduces significant uncertainty and potential legal costs.

  • · The BCA was originally entered into on April 21, 2025, and amended on September 26, 2025.
  • · The termination was purportedly made under Section 9.1(f)(i) of the BCA.
  • · The SPAC disputes the termination and has not admitted to any assertions in the notice.
  • · The SPAC's securities are traded on the OTC market under symbols PPYAU, PPYA, and PPYAW.
  • · The SPAC is an emerging growth company.
CoreWeave, Inc. 8-K neutral materiality 8/10

18-06-2026

CoreWeave, Inc. completed a private offering of $1,250 million in 9.625% Senior Notes due 2032 and €2,000 million in 8.500% Senior Notes due 2032 on June 18, 2026. The notes are guaranteed on a senior unsecured basis by certain wholly-owned subsidiaries and are subject to customary covenants and change-of-control repurchase provisions. Proceeds will be used for general corporate purposes, including repayment of outstanding indebtedness and offering expenses.

  • · The Senior Notes mature on July 15, 2032, with interest payable semi-annually on January 15 and July 15, beginning January 15, 2027.
  • · Interest accrues from June 18, 2026.
  • · CoreWeave may redeem the notes prior to July 15, 2029 at 100% of principal plus a make-whole premium; after that date, at specified redemption prices.
  • · Up to 40% of each series may be redeemed with net cash proceeds from certain equity offerings before July 15, 2029.
  • · Upon a change-of-control triggering event, holders can require repurchase at 101% of principal plus accrued interest.
  • · The indentures include covenants limiting additional indebtedness, dividends, liens, investments, asset sales, affiliate transactions, mergers, and designation of unrestricted subsidiaries.
  • · Customary events of default with grace and cure periods apply.
  • · The offering was made to qualified institutional buyers under Rule 144A of the Securities Act.
Otter Tail Corp 8-K negative materiality 7/10

18-06-2026

Otter Tail Corp entered into a $30 million settlement agreement on June 17, 2026 to resolve claims by the End-User Class in the consolidated PVC Pipe Antitrust Litigation. The settlement, which requires court approval, covers all EUP claims against the company and its subsidiaries but does not constitute an admission of wrongdoing. The company expects to fund the payment from available cash and does not anticipate a material adverse effect on its financial position or liquidity.

  • · The settlement is subject to preliminary and final court approval; payment due ~21 days after preliminary approval.
  • · The settlement amount includes recovery for class members, attorneys' fees, and administration costs.
  • · The company does not admit any wrongdoing, fault, or liability.
  • · The ultimate outcome of the PVC Pipe Antitrust Litigation remains uncertain; if settlement is not finalized, the company intends to continue defending itself.
  • · The settlement is not expected to have a material adverse effect on the company's financial position or liquidity.
Denali Therapeutics Inc. 8-K positive materiality 8/10

18-06-2026

Denali Therapeutics entered a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $195 million in gross proceeds, following the FDA's March 2026 accelerated approval of AVLAYAH (tividenofusp alfa-eknm) for Hunter syndrome. The proceeds will support Denali's clinical portfolio for lysosomal storage disorders and neurodegenerative diseases, including programs for Sanfilippo syndrome, frontotemporal dementia, Pompe disease, and Alzheimer's. The transaction is subject to customary closing conditions, including antitrust review.

  • · AVLAYAH is the first FDA-approved biologic designed to cross the blood-brain barrier via transferrin receptor-mediated transport.
  • · Denali's clinical-stage portfolio includes DNL126 for Sanfilippo syndrome type A, DNL593 for GRN-related frontotemporal dementia, DNL952 for Pompe disease, and DNL628 for Alzheimer's disease.
  • · Multiple programs are in IND-enabling stage, including DNL921 for Alzheimer's, DNL111 for Parkinson's and Gaucher disease, DNL622 for Hurler syndrome, and DNL422 for Parkinson's disease.
  • · The PRV transaction is subject to expiration of the Hart-Scott Rodino waiting period.
  • · Denali's TransportVehicle platform demonstrates >10- to 30-fold greater brain exposure for antibodies and enzymes, and >1,000-fold greater for oligonucleotides in primates compared to non-engineered counterparts.
Commercial Vehicle Group, Inc. 8-K neutral materiality 6/10

18-06-2026

Commercial Vehicle Group, Inc. (CVGI) entered into a Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC on June 18, 2026, allowing the company to sell up to $25,000,000 of its common stock through at-the-market offerings. The company will pay a 3.0% commission on gross sales price per share sold through the sales agent. The agreement provides CVGI with flexible access to capital but also introduces potential dilution for existing shareholders if shares are sold.

  • · The Sales Agreement is dated June 18, 2026.
  • · Shares may be sold in 'at the market' offerings as defined in Rule 415(a)(4) under the Securities Act.
  • · The company is not obligated to sell any shares and may suspend solicitations at any time.
  • · The offering is made under an effective registration statement on Form S-3 (File No. 333-296502), as amended, declared effective June 12, 2026.
  • · A prospectus supplement was filed with the SEC on June 18, 2026.
  • · The company will reimburse the Sales Agent for certain specified expenses in connection with entering into the agreement.
  • · The legal opinion of Baker & Hostetler LLP regarding the validity of the shares is filed as Exhibit 5.1.
DYADIC INTERNATIONAL INC 8-K negative materiality 9/10

18-06-2026

Dyadic International received a delisting notification from Nasdaq on June 18, 2026, for failing to maintain a minimum bid price of $1.00 per share (Bid Price Rule) and for not meeting the Continued Listing Standards (minimum $2.5M shareholders' equity, $35M market value, or $500K net income). The company had until June 17, 2026, to regain compliance but did not, and also failed to meet the condition for an extension (shareholders' equity of $5M). Dyadic plans to request a hearing before a Nasdaq panel, which will automatically stay any delisting action at least through the panel's written decision, but there is no assurance of regaining compliance or avoiding delisting.

  • · The company had until June 17, 2026, to regain compliance with the Bid Price Rule but failed.
  • · The company did not meet the condition for an extension (shareholders' equity of $5M) as of June 17, 2026.
  • · The Continued Listing Standards deficiency serves as an additional basis for delisting.
  • · The maximum extension that could be granted by the Panel runs through December 15, 2026.
  • · An adverse Panel decision may be appealed to the Nasdaq Listing and Hearing Review Council.
FOCUS UNIVERSAL INC. 8-K neutral materiality 7/10

18-06-2026

Focus Universal Inc. filed a Certificate of Amendment to effect a 1-for-4 reverse stock split of its common stock, effective June 22, 2026 at 9:01 p.m. The amendment was approved by shareholders representing 51.69% of outstanding voting power. No fractional shares will be issued; holders otherwise entitled to a fractional share will receive a cash payment based on the Nasdaq closing price on the effective date.

  • · The reverse stock split ratio is 1-for-4.
  • · Effective date and time: June 22, 2026 at 9:01 p.m.
  • · Par value remains $0.001 per share after the split.
  • · No fractional shares will be issued; fractional interests will be cashed out based on the Nasdaq closing price on the effective date.
  • · The amendment was approved by holders of 51.69% of outstanding voting power.
  • · The filing was made with the Nevada Secretary of State on June 18, 2026.

Get daily alerts with 10 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Corporate Distress Financial Stress SEC Filings

🇺🇸 More from United States

View all →